Consequences of switching from a fixed 2: 1 ratio of amoxicillin/clavulanate (CLSI) to a fixed concentration of clavulanate (EUCAST) for susceptibility testing of Escherichia coli

Maurine A. Leverstein-van Hall*, Karola Waar, Jan Muilwijk, James Cohen Stuart,

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Consequences of switching from a fixed 2: 1 ratio of amoxicillin/clavulanate (CLSI) to a fixed concentration of clavulanate (EUCAST) for susceptibility testing of Escherichia coli'. Together they form a unique fingerprint.

Immunology and Microbiology